CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest
Beginning balance (in shares) at Dec. 31, 2022		412,385
Beginning balance at Dec. 31, 2022	$ 1,040,609	$ 4,124	$ 2,106,886	$ (1,064,230)	$ (5,560)	$ (611)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(836)			(727)		(109)
Other comprehensive income (loss)	(809)				(809)
Exercise of stock options (in shares)		2,267
Exercise of stock options	10,545	$ 22	10,523
Vesting of restricted stock units (in shares)		452
Vesting of restricted stock units	0	$ 5	(5)
Shares withheld related to net share settlement (in shares)		(62)
Shares withheld related to net share settlement	(1,743)	$ (1)	(1,742)
Common stock repurchase (in shares)		(9,615)
Common stock repurchase	(201,564)	$ (96)	(201,468)
Stock-based compensation expense	33,244		33,244
Ending balance, (in shares) at Jun. 30, 2023		405,427
Ending balance at Jun. 30, 2023	879,446	$ 4,054	1,947,438	(1,064,957)	(6,369)	(720)
Beginning balance (in shares) at Mar. 31, 2023		414,465
Beginning balance at Mar. 31, 2023	1,081,840	$ 4,145	2,130,126	(1,048,208)	(3,549)	(674)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(16,795)			(16,749)		(46)
Other comprehensive income (loss)	(2,820)				(2,820)
Exercise of stock options (in shares)		265
Exercise of stock options	928	$ 2	926
Vesting of restricted stock units (in shares)		373
Vesting of restricted stock units	0	$ 4	(4)
Shares withheld related to net share settlement (in shares)		(61)
Shares withheld related to net share settlement	(1,715)	$ (1)	(1,714)
Common stock repurchase (in shares)		(9,615)
Common stock repurchase	(201,564)	$ (96)	(201,468)
Stock-based compensation expense	19,572		19,572
Ending balance, (in shares) at Jun. 30, 2023		405,427
Ending balance at Jun. 30, 2023	$ 879,446	$ 4,054	1,947,438	(1,064,957)	(6,369)	(720)
Beginning balance (in shares) at Dec. 31, 2023	406,387	406,387
Beginning balance at Dec. 31, 2023	$ 661,021	$ 4,064	1,986,899	(1,326,826)	(2,298)	(818)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(36,696)			(36,746)		50
Other comprehensive income (loss)	(149)				(149)
Exercise of stock options (in shares)		1,476
Exercise of stock options	2,626	$ 15	2,611
Vesting of restricted stock units (in shares)		1,860
Vesting of restricted stock units	0	$ 17	(17)
Shares withheld related to net share settlement (in shares)		(250)
Shares withheld related to net share settlement	(1,281)	$ (2)	(1,279)
Issuance of common stock (in shares)		1,974
Issuance of common stock	15,230	$ 20	15,210
Stock-based compensation expense	$ 35,116		35,116
Ending balance, (in shares) at Jun. 30, 2024	411,447	411,447
Ending balance at Jun. 30, 2024	$ 675,867	$ 4,114	2,038,540	(1,363,572)	(2,447)	(768)
Beginning balance (in shares) at Mar. 31, 2024		410,843
Beginning balance at Mar. 31, 2024	688,486	$ 4,108	2,020,803	(1,332,890)	(2,747)	(788)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(30,662)			(30,682)		20
Other comprehensive income (loss)	300				300
Exercise of stock options (in shares)		42
Exercise of stock options	171	$ 1	170
Vesting of restricted stock units (in shares)		690
Vesting of restricted stock units	0	$ 6	(6)
Shares withheld related to net share settlement (in shares)		(128)
Shares withheld related to net share settlement	(635)	$ (1)	(634)
Stock-based compensation expense	$ 18,207		18,207
Ending balance, (in shares) at Jun. 30, 2024	411,447	411,447
Ending balance at Jun. 30, 2024	$ 675,867	$ 4,114	$ 2,038,540	$ (1,363,572)	$ (2,447)	$ (768)